Kombucha
Health Effects from Human Trials
John Slough
This is not medical advice
Potential Benefits:
A prospective randomized double-blinded crossover study, with 12 subjects
“Kombucha lowered average fasting blood glucose levels at 4 weeks compared to baseline (164 vs. 116 mg/dL, p = 0.035), whereas the placebo did not (162 vs. 141 mg/dL, p = 0.078).”
“paired analysis between baseline and end of intervention time points within kombucha or control groups revealed increases in fasting insulin and in HOMA-IR in the kombucha group”
2023 Study, 11 participants, on post-prandial glucose response of kombucha compared to 2 other drinks
The Kombucha added 3g of carbohydrate (1.7g sugar) to the test meal
Soda water and diet lemonade did not contain any sugar.
Conclusion: A standard serving of kombucha, consumed with a high-GI, rice-based meal:
2024 RCT: Kombucha and the Gut Microbiome
8-week trial in 30 healthy adults
No change in overall diversity, but specific species shifted
Probiotic increases:
Weizmannia coagulans — probiotic added to kombucha
SCFA producers (e.g. Prevotella, Bifidobacterium) → may support gut lining and reduce inflammation
Ellagibacter — helps break down dietary polyphenols
Probiotic decreases:
↓ Fusobacterium, Parabacteroides — possibly favorable
↓ Lactobacillus — often beneficial; unclear impact here
No effect on blood biomarkers or inflammation
Suggests short-term microbial reshaping from probiotics + fiber;
clinical impact unclear without longer trials
10 week study on 59 participants from 2024
Note: Only “not completely emptying the intestine” showed a statistically significant difference in change (Δ) between groups (p = 0.002); other p-values reflect final score comparisons.
The study on green tea kombucha states:
“Kombucha has been associated with decreasing gastrointestinal symptoms in individuals with inflammatory bowel disease [17].”
But reference [17] is a pilot RCT in women with IBS-C — it does not mention IBD or its subtypes (Crohn’s, ulcerative colitis)
A Google Scholar search for “kombucha inflammatory bowel disease” ranks the IBS study among the top results
How citation distortions create unfounded authority: analysis of a citation network
Study involved 59 subjects
blunt IL-6 increase vs. control (IL-6 increased in both groups)
unclear if this blunting is clinically significant (it is statistically)
reduce lipid accumulation product (LAP) (p = 0.029)
Human Evidence:
No human randomized controlled trials have directly measured anti-oxidant biomarkers
Reviews emphasize a lack of direct anti-oxidant outcome trials in humans
Animal & in vitro evidence:
Strong preclinical data support kombucha as a liver-support candidate, but no direct human evidence yet.
Mild GI symptoms common in trials (e.g. bloating, diarrhea) (Ecklu-Mensah et al., 2024)
Serious liver injury reported:
Case of acute cholestatic hepatitis after ~1 month of kombucha use
in a woman with diabetes and hypothyroidism; resolved with treatment
Iowa CDC case (1995):
Two women hospitalized after drinking homemade kombucha for 2 months;
one died from severe metabolic acidosis
“Possibly Associated with Consumption of Kombucha Tea”
Caution: Most serious harms involved improperly prepared homemade or excessive daily use.
When brewed safely and consumed in moderation, kombucha appears well-tolerated by most.
Kombucha appears possibly helpful for digestion and glycemic response in some people,
but larger human trials are needed to draw confident health conclusions.